Cargando…

Early clinical signs in lysosomal diseases

BACKGROUND AND AIM: The lysosomal storage diseases are a group of monogenic diseases with multisystemic impairment and chronic progression induced by the deficiency of lysosomal acid hydrolases involved in the breakdown of various macromolecules. The accumulation occurs in the macrophages of the ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkhzouz, Camelia, Miclea, Diana, Bucerzan, Simona, Lazea, Cecilia, Nascu, Ioana, Sido, Paula Grigorescu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411815/
https://www.ncbi.nlm.nih.gov/pubmed/34527909
http://dx.doi.org/10.15386/mpr-2228
_version_ 1783747351380230144
author Alkhzouz, Camelia
Miclea, Diana
Bucerzan, Simona
Lazea, Cecilia
Nascu, Ioana
Sido, Paula Grigorescu
author_facet Alkhzouz, Camelia
Miclea, Diana
Bucerzan, Simona
Lazea, Cecilia
Nascu, Ioana
Sido, Paula Grigorescu
author_sort Alkhzouz, Camelia
collection PubMed
description BACKGROUND AND AIM: The lysosomal storage diseases are a group of monogenic diseases with multisystemic impairment and chronic progression induced by the deficiency of lysosomal acid hydrolases involved in the breakdown of various macromolecules. The accumulation occurs in the macrophages of the reticule-endothelial system and causes enlargement and functional impairment. The mainly involved organs are the brain, liver, spleen, bones, joints, airways, lungs, and heart. The aim of this study was to evaluate early symptoms, signs and the delay in the diagnosis of different lysosomal diseases. METHODS: The medical documentation of 188 patients with lysosomal storage disorders, aged 1–70 years, were analyzed. All these patients were specifically diagnosed, by enzyme and molecular assay. RESULTS: The age of clinical signs onset varies in different type of lysosomal diseases, from the first months of life or early childhood in severe form, to adulthood in attenuated forms. The delay between the clinical signs onset and specific diagnosis ranged from 0.5 months to 57.91 years. CONCLUSIONS: The lysosomal storage diseases are rare diseases with childhood onset, but these early signs and symptoms are not recognized and are often taken into account when the vital organs damage becomes manifest.
format Online
Article
Text
id pubmed-8411815
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-84118152021-09-14 Early clinical signs in lysosomal diseases Alkhzouz, Camelia Miclea, Diana Bucerzan, Simona Lazea, Cecilia Nascu, Ioana Sido, Paula Grigorescu Med Pharm Rep Articles BACKGROUND AND AIM: The lysosomal storage diseases are a group of monogenic diseases with multisystemic impairment and chronic progression induced by the deficiency of lysosomal acid hydrolases involved in the breakdown of various macromolecules. The accumulation occurs in the macrophages of the reticule-endothelial system and causes enlargement and functional impairment. The mainly involved organs are the brain, liver, spleen, bones, joints, airways, lungs, and heart. The aim of this study was to evaluate early symptoms, signs and the delay in the diagnosis of different lysosomal diseases. METHODS: The medical documentation of 188 patients with lysosomal storage disorders, aged 1–70 years, were analyzed. All these patients were specifically diagnosed, by enzyme and molecular assay. RESULTS: The age of clinical signs onset varies in different type of lysosomal diseases, from the first months of life or early childhood in severe form, to adulthood in attenuated forms. The delay between the clinical signs onset and specific diagnosis ranged from 0.5 months to 57.91 years. CONCLUSIONS: The lysosomal storage diseases are rare diseases with childhood onset, but these early signs and symptoms are not recognized and are often taken into account when the vital organs damage becomes manifest. Iuliu Hatieganu University of Medicine and Pharmacy 2021-08 2021-08-10 /pmc/articles/PMC8411815/ /pubmed/34527909 http://dx.doi.org/10.15386/mpr-2228 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
spellingShingle Articles
Alkhzouz, Camelia
Miclea, Diana
Bucerzan, Simona
Lazea, Cecilia
Nascu, Ioana
Sido, Paula Grigorescu
Early clinical signs in lysosomal diseases
title Early clinical signs in lysosomal diseases
title_full Early clinical signs in lysosomal diseases
title_fullStr Early clinical signs in lysosomal diseases
title_full_unstemmed Early clinical signs in lysosomal diseases
title_short Early clinical signs in lysosomal diseases
title_sort early clinical signs in lysosomal diseases
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411815/
https://www.ncbi.nlm.nih.gov/pubmed/34527909
http://dx.doi.org/10.15386/mpr-2228
work_keys_str_mv AT alkhzouzcamelia earlyclinicalsignsinlysosomaldiseases
AT micleadiana earlyclinicalsignsinlysosomaldiseases
AT bucerzansimona earlyclinicalsignsinlysosomaldiseases
AT lazeacecilia earlyclinicalsignsinlysosomaldiseases
AT nascuioana earlyclinicalsignsinlysosomaldiseases
AT sidopaulagrigorescu earlyclinicalsignsinlysosomaldiseases